Evidence map›Paper›PMID 40557870›Full record

ArticleNucleic acids research2025

Mechanistic studies of small molecule ligands selective to RNA single G bulges.

Shalakha Hegde, Sana Akhter, Zhichao Tang, Chang Qi, Chenguang Yu, Anna Lewicka, Yu Liu, Kushal Koirala, Mikhail Reibarkh, Kevin P Battaile and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Depleting prion protein using splice-switching small molecules.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Shalakha HegdeSection of Genetic Medicine, Department of Medicine, Biological Sciences Division, University of Chicago, Chicago, IL 60637, United States.
Sana AkhterDepartment of Pharmacology and Computational Medicine Program, University of North Carolina, Chapel Hill, NC 27599, United States.
Zhichao TangSection of Genetic Medicine, Department of Medicine, Biological Sciences Division, University of Chicago, Chicago, IL 60637, United States.
Chang QiAnalytical Research & Development, Merck & Co., Inc, Rahway, NJ 07065, United States.
Chenguang YuCalibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, United States.
Anna LewickaDepartment of Biochemistry and Molecular Biology, Biological Sciences Division, University of Chicago, Chicago, IL 60637, United States.ORCID 0000-0002-9578-2628
Yu LiuDepartment of Chemistry, Rockhurst University, Kansas City, MO 64110, United States.
Kushal KoiralaDepartment of Pharmacology and Computational Medicine Program, University of North Carolina, Chapel Hill, NC 27599, United States.
Mikhail ReibarkhAnalytical Research & Development, Merck & Co., Inc, Rahway, NJ 07065, United States.
Kevin P BattaileNew York Structural Biology Center, Upton, NY 11973, United States.
Anne CooperProtein Structure and X-ray Crystallography Laboratory, University of Kansas, Lawrence, KS 66047, United States.
Scott LovellProtein Structure and X-ray Crystallography Laboratory, University of Kansas, Lawrence, KS 66047, United States.
Erik D HolmstromDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, United States.ORCID 0000-0003-2624-0806
Xiao WangAnalytical Research & Development, Merck & Co., Inc, Rahway, NJ 07065, United States.
Joseph A PiccirilliDepartment of Biochemistry and Molecular Biology, Biological Sciences Division, University of Chicago, Chicago, IL 60637, United States.ORCID 0000-0002-0541-6270
Qi GaoAnalytical Research & Development, Merck & Co., Inc, Rahway, NJ 07065, United States.
Yinglong MiaoDepartment of Pharmacology and Computational Medicine Program, University of North Carolina, Chapel Hill, NC 27599, United States.ORCID 0000-0002-9809-5428
Jingxin WangSection of Genetic Medicine, Department of Medicine, Biological Sciences Division, University of Chicago, Chicago, IL 60637, United States.ORCID 0000-0002-9414-4093

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Vivian Stojanoff · 2019 to 2026
$38.6M
Structure and Function of Non-Coding RNAR35GM149336 · NIGMS · UNIVERSITY OF CHICAGO · PI Joseph Anthony Piccirilli · 2023 to 2026
$2.8M
Modulating gene expression by RNA-targeting chimerasR35GM147498 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI Jingxin Wang · 2022 to 2026
$2.1M
An Eiger2 XE 9M detector for the NYSBC-operated NYX beamline at NSLS-IIS10OD030394 · OD · NEW YORK STRUCTURAL BIOLOGY CENTER · PI BATTAILE, KEVIN P · 2021 to 2021
$1.8M
Biological and Environmental Research KP1607011Center Core P30 P30GM133893Center for Bio-Molecular Structure (CBMS)NECAT BAG 311950New York Structural Biology CenterNIGMS NIH HHS P30 GM133893NIGMS NIH HHS R35 GM147498NIGMS NIH HHS R35 GM149336NIH HHS R35GM147498NIH HHS S10 OD030394University of North CarolinaU.S. Department of Energy DE-SC0012704U.S. Department of Energy S10OD030394U.S. DOE Office of Science DE-SC0012704
6 · The paper itself

Abstract

Small-molecule RNA binders have emerged as an important pharmacological modality. A profound understanding of the ligand selectivity, binding mode, and influential factors governing ligand engagement with RNA targets is the foundation for rational ligand design. Here, we report a novel class of coumarin derivatives exhibiting selective binding affinity towards single G RNA bulges. Harnessing the computational power of all-atom Gaussian accelerated molecular dynamics simulations, we unveiled a rare minor groove binding mode of the ligand with a key interaction between the coumarin moiety and the G bulge. This predicted binding mode is consistent with results obtained from structure-activity relationship studies and transverse relaxation measurements by nuclear magnetic resonance spectroscopy. We further generated 444 molecular descriptors from 69 coumarin derivatives and identified key contributors to the binding events, such as charge state and planarity, by lasso (least absolute shrinkage and selection operator) regression. Our work deepened the understanding of RNA-small molecule interactions and integrated a new framework for the rational design of selective small-molecule RNA binders.

Indexed as

CoumarinsRNASmall Molecule LibrariesBinding SitesLigandsMolecular Dynamics SimulationNucleic Acid ConformationStructure-Activity RelationshipCoumarinsLigandsRNASmall Molecule Libraries

Identifiers

PMID40557870
PMCPMC12188297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.